March 17th 2025
The vaccine is based on an attenuated rabies vaccine that was subsequently inactivated to make the vaccine candidate. The National Institutes of Health (NIH) is sponsoring the trial.
Exploring the Dual Benefits of COVID-19 Vaccination in Mitigating Asthma Symptoms in Children
Published: July 11th 2024 | Updated: July 11th 2024Matthew M Davis, MD, MAPP elaborates on how higher COVID-19 vaccination rates may curb the virus, alleviate childhood asthma symptoms, and protect against other common colds.
Read More
Immune Response Dynamics in Solid Organ Transplant Recipients After Omicron Booster Vaccinations
July 3rd 2024Boosted neutralization against variant XBB15 fades within 3 months post-first booster in transplant recipients but improves with a second, hybrid immunity enhances, suggesting 3-6 month boost intervals for solid organ transplant recipients.
Read More
Are Combination Respiratory Virus Vaccines the Way of the Future?
June 19th 2024With the recent phase 3 data results of the Moderna COVID-19-influenza combination vaccine, the company is working towards regulatory approval and opens the door to possible protection against multiple viruses with less immunizations.
Watch
Moderna’s Influenza-COVID-19 Combination Vaccine Elicits Immune Response in Older Adults
June 10th 2024The company announced data this morning for its investigational mRNA-1083 vaccine and plans to continue collecting data and working towards submitting a Biological License Application (BLA) for it.
Read More